⌘K

Login Start Free

Home/Filings/4/0001127602-25-004391

4//SEC Filing

Hykes Andrew 4

Accession 0001127602-25-004391

CIK 0001531048other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:42 PM ET

Size

16.6 KB

Accession

0001127602-25-004391

Insider Transaction Report

Form 4

Period: 2025-02-10

Inari Medical, Inc.NARI

DirectorPresident and CEO

Transactions

Exercise/Conversion
Stock Option
2025-02-10−16,719→ 0 total
Exercise: $0.46Exp: 2029-03-12→ Common Stock (16,719 underlying)
Exercise/Conversion
Common Stock
2025-02-10$0.43/sh+161,100$69,015→ 663,806 total
Exercise/Conversion
Common Stock
2025-02-10$6.45/sh+16,719$107,914→ 680,525 total
Exercise/Conversion
Common Stock
2025-02-10$0.46/sh+16,719$7,639→ 697,244 total
Exercise/Conversion
Stock Options (Right to Buy)
2025-02-10−161,100→ 0 total
Exercise: $0.43Exp: 2028-05-03→ Common Stock (161,100 underlying)
Exercise/Conversion
Stock Option
2025-02-10−16,719→ 0 total
Exercise: $6.45Exp: 2030-01-17→ Common Stock (16,719 underlying)

Holdings

Common Stock
(indirect: By Children)
1,550
Common Stock
(indirect: By Children)
1,550
Common Stock
(indirect: By Children)
1,550
Common Stock
(indirect: By Spouse)
1,000

Footnotes (3)

[F1]The option became fully vested and exercisable as of March 29, 2022.
[F2]The option became fully vested and exercisable as of January 1, 2024.
[F3]The option became fully vested and exercisable as of January 1, 2023.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Inari Medical, Inc.

CIK 0001531048

Entity typeother

Related Parties

1

filerCIK 0001806431

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 4:42 PM ET
Size: 16.6 KB

View on SEC.gov